Literature DB >> 20071700

Morphine use after combat injury in Iraq and post-traumatic stress disorder.

Troy Lisa Holbrook1, Michael R Galarneau, Judy L Dye, Kimberly Quinn, Amber L Dougherty.   

Abstract

BACKGROUND: Post-traumatic stress disorder (PTSD) is a common adverse mental health outcome among seriously injured civilians and military personnel who are survivors of trauma. Pharmacotherapy in the aftermath of serious physical injury or exposure to traumatic events may be effective for the secondary prevention of PTSD.
METHODS: We identified 696 injured U.S. military personnel without serious traumatic brain injury from the Navy-Marine Corps Combat Trauma Registry Expeditionary Medical Encounter Database. Complete data on medications administered were available for all personnel selected. The diagnosis of PTSD was obtained from the Career History Archival Medical and Personnel System and verified in a review of medical records.
RESULTS: Among the 696 patients studied, 243 received a diagnosis of PTSD and 453 did not. The use of morphine during early resuscitation and trauma care was significantly associated with a lower risk of PTSD after injury. Among the patients in whom PTSD developed, 61% received morphine; among those in whom PTSD did not develop, 76% received morphine (odds ratio, 0.47; P<0.001). This association remained significant after adjustment for injury severity, age, mechanism of injury, status with respect to amputation, and selected injury-related clinical factors.
CONCLUSIONS: Our findings suggest that the use of morphine during trauma care may reduce the risk of subsequent development of PTSD after serious injury. 2010 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071700     DOI: 10.1056/NEJMoa0903326

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  111 in total

1.  OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV.

Authors:  Nicole R Nugent; Michelle A Lally; Larry Brown; Valerie S Knopik; John E McGeary
Journal:  AIDS Behav       Date:  2012-11

2.  Remembered for forgetting.

Authors:  Cassandra Willyard
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

3.  Letter to the Editor: Trauma pain - a military perspective.

Authors:  Christina Davies; Winston F de Mello
Journal:  Br J Pain       Date:  2013-08

Review 4.  Prevention of Trauma and Stressor-Related Disorders: A Review.

Authors:  Jonathon R Howlett; Murray B Stein
Journal:  Neuropsychopharmacology       Date:  2015-08-28       Impact factor: 7.853

5.  Making lasting memories: remembering the significant.

Authors:  James L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

6.  The development of a population-based automated screening procedure for PTSD in acutely injured hospitalized trauma survivors.

Authors:  Joan Russo; Wayne Katon; Douglas Zatzick
Journal:  Gen Hosp Psychiatry       Date:  2013-06-24       Impact factor: 3.238

7.  Differential effects of early postinjury treatment with neuroprotective drugs in a mouse model using diffuse reflectance spectroscopy.

Authors:  Ariel Shochat; David Abookasis
Journal:  Neurophotonics       Date:  2015-01-22       Impact factor: 3.593

Review 8.  [Depressive, anxiety and posttraumatic stress disorders as long-term sequelae of intensive care treatment].

Authors:  H-P Kapfhammer
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

10.  A randomized stepped care intervention trial targeting posttraumatic stress disorder for surgically hospitalized injury survivors.

Authors:  Douglas Zatzick; Gregory Jurkovich; Frederick P Rivara; Joan Russo; Amy Wagner; Jin Wang; Chris Dunn; Sarah Peregrine Lord; Megan Petrie; Stephen S Oʼconnor; Wayne Katon
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.